Identification of new functional regions in hepatitis C virus envelope glycoprotein E2

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1777-1792

  Albecka, Anna ^a,b   Montserret, Roland ^c   Krey, Thomas ^d   Tarr, Alexander W ^e   Diesis, Eric ^c   Ball, Jonathan K ^e   Descamps, Véronique ^f   Duverlie, Gilles ^f   Rey, Felix ^d   Penin, François ^c   Dubuisson, Jean ^a,b  

^a INSERM U1019   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ DE LYON   (France)

^d CNRS   (France)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; GLYCOPROTEIN E1; GLYCOPROTEIN E2;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; GENETIC INCOMPATIBILITY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MEMBRANE BINDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; VIRUS ENTRY; VIRUS PARTICLE;

HEPATITIS C VIRUS;

EID: 78951475433     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02170-10     Document Type: Article

References (78)

1. Bartosch, B., J. Dubuisson, and F. L. Cosset. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
2. Brohm, C., et al. 2009. Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation. J. Virol. 83:11682-11693.
3. Buck, M. 1998. Trifluoroethanol and colleagues: cosolvents come of age: recent studies with peptides and proteins. Q. Rev. Biophys. 31:297-355.
4. Choo, Q. L., et al. 1989. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 244:359-362.
5. Ciczora, Y., et al. 2005. Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J. Gen. Virol. 86:2793-2798.
6. Ciczora, Y., N. Callens, F. Penin, E. I. Pecheur, and J. Dubuisson. 2007. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J. Virol. 81:2372-2381.
7. Cocquerel, L., C. C. Kuo, J. Dubuisson, and S. Levy. 2003. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J. Virol. 77:10677-10683.
8. Cocquerel, L., et al. 2002. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins. EMBO J. 21:2893-2902.
9. Combet, C., C. Blanchet, C. Geourjon, and G. Deleage. 2000. NPS@: network protein sequence analysis. Trends Biochem. Sci. 25:147-150.
10. Combet, C., et al. 2007. euHCVdb: the European hepatitis C virus database. Nucleic Acids Res. 35:D363-D366.
11. Deleersnyder, V., et al. 1997. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71:697-704.
12. Delgrange, D., et al. 2007. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J. Gen. Virol. 88:2495-2503.
13. Drummer, H. E., I. Boo, A. L. Maerz, and P. Poumbourios. 2006. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. J. Virol. 80:7844-7853.
14. Drummer, H. E., A. Maerz, and P. Poumbourios. 2003. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 546:385-390.
15. Drummer, H. E., and P. Poumbourios. 2004. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. J. Biol. Chem. 279:30066-30072.
16. Dubuisson, J., et al. 1994. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68:6147-6160.
17. Dubuisson, J., F. Penin, and D. Moradpour. 2002. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 12:517-523.
18. Favier, A., et al. 2002. Solution structure and dynamics of Crh, the Bacillus subtilis catabolite repression HPr. J. Mol. Biol. 317:131-144.
19. Flint, M., et al. 2000. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 74:702-709.
20. Flint, M., et al. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:6235-6244.
21. Forns, X., et al. 2000. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 97:13318-13323.
22. Gibbons, D. L., et al. 2003. Visualization of the target-membrane- inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 114:573-583.
23. Gibbons, D. L., et al. 2004. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427:320-325.
24. Gottwein, J. M., et al. 2009. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364-377.
25. Goueslain, L., et al. 2010. Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J. Virol. 84:773-787.
26. Granseth, E., G. von Heijne, and A. Elofsson. 2005. A study of the membrane-water interface region of membrane proteins. J. Mol. Biol. 346:377-385.
27. Haid, S., T. Pietschmann, and E. I. Pecheur. 2009. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J. Biol. Chem. 284:17657-17667.
28. Helle, F., et al. 2007. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J. Virol. 81:8101-8111.
29. Hsu, M., et al. 2003. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 100:7271-7276.
30. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38, 27-28.
31. Iacob, R. E., Z. Keck, O. Olson, S. K. Foung, and K. B. Tomer. 2008. Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein. Biochim. Biophys. Acta 1784:530-542.
32. Kielian, M., and F. A. Rey. 2006. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev. Microbiol. 4:67-76.
33. Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55, 29-32.
34. Krey, T., et al. 2010. The disulfide bonds in glycoprotein e2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS. Pathog. 6:e1000762.
35. Kuiken, C., et al. 2006. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 44:1355-1361.
36. Kuiken, C., and P. Simmonds. 2009. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 510:33-53.
37. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
38. Lavie, M., A. Goffard, and J. Dubuisson. 2007. Assembly of a functional HCV glycoprotein heterodimer. Curr. Issues Mol. Biol. 9:71-86.
39. Lavillette, D., et al. 2006. Hepatitis C virus glycoproteins mediate low pHdependent membrane fusion with liposomes. J. Biol. Chem. 281:3909-3917.
40. Lavillette, D., et al. 2007. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81:8752-8765.
41. Lemon, S. M., C. Walker, M. J. Alter, and M. Yi. 2007. Hepatitis virus, p. 1253-1304. In D. M. Knipe, et al. (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
42. Lindenbach, B. D., et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
43. Marcellin, P. 2009. Hepatitis B and hepatitis C in 2009. Liver Int. 29(Suppl.1):1-8.
44. McCaffrey, K., I. Boo, P. Poumbourios, and H. E. Drummer. 2007. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding. J. Virol. 81:9584-9590.
45. McCaffrey, K., H. Gouklani, I. Boo, P. Poumbourios, and H. E. Drummer. 2011. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity. J. Gen. Virol. 92:112-121.
46. McKeating, J. A., et al. 2004. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78:8496-8505.
47. Mederacke, I., et al. 2009. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J. Clin. Virol. 46:210-215.
48. Merutka, G., H. J. Dyson, and P. E. Wright. 1995. 'Random coil' 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG. J. Biomol. NMR 5:14-24.
49. Miyanari, Y., et al. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
50. Montserret, R., et al. 1999. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR. Biochemistry 38:6479-6488.
51. Morota, K., et al. 2009. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J. Virol. Methods 157:8-14.
52. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42:3858-3863.
53. Op De Beeck, A., et al. 2000. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J. Biol. Chem. 275:31428-31437.
54. Op De Beeck, A., et al. 2004. Characterization of functional hepatitis C virus envelope glycoproteins. J. Virol. 78:2994-3002.
55. Opella, S. J. 1997. NMR and membrane proteins. Nat. Struct. Biol. 4(Suppl.):845-848.
56. Owsianka, A. M., et al. 2006. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J. Virol. 80:8695-8704.
57. Penin, F., J. Dubuisson, F. A. Rey, D. Moradpour, and J. M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39:5-19.
58. Penin, F., et al. 1997. Three-dimensional structure of the DNA-binding domain of the fructose repressor from Escherichia coli by 1H and 15N NMR. J. Mol. Biol. 270:496-510.
59. Perez-Berna, A. J., M. R. Moreno, J. Guillen, A. Bernabeu, and J. Villalain. 2006. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. Biochemistry 45:3755-3768.
60. Pileri, P., et al. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
61. Popescu, C. I., and J. Dubuisson. 2010. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol. Cell 102:63-74.
62. Rothwangl, K. B., B. Manicassamy, S. L. Uprichard, and L. Rong. 2008. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol. J. 5:46.
63. Russell, R. S., et al. 2009. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles. J. Viral Hepat. 16:621-632.
64. Sandrin, V., et al. 2005. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J. Gen. Virol. 86:3189-3199.
65. Schwarzinger, S., et al. 2001. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123:2970-2978.
66. Schwieters, C. D., J. J. Kuszewski, N. Tjandra, and G. M. Clore. 2003. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160:65-73.
67. Simmonds, P., et al. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
68. Tarr, A. W., et al. 2006. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 43:592-601.
69. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
70. Vieyres, G., et al. 2010. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J. Virol. 84:10159-10168.
71. Wakita, T., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
72. Wasley, A., and M. J. Alter. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 20:1-16.
73. Whitmore, L., and B. A. Wallace. 2004. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32:W668-W673.
74. Wimley, W. C., and S. H. White. 1996. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3:842-848.
75. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1992. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
76. Wuthrich, K. 1986. NMR of proteins and nucleic acids. J. Wiley and Sons, New York, NY.
77. Yi, M., Y. Ma, J. Yates, and S. M. Lemon. 2007. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 81:629-638.
78. Zhong, J., et al. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.